The cell sorter market was valued at $0.5 billion in 2022 and is estimated to reach $1.3 billion by 2032, exhibiting a CAGR of 8.6% from 2023 to 2032. Cell sorter is an instrument that is used for biological and medical research to isolate, analyze, and sort cells based on their physical and chemical properties. In addition, cell sorters are used in several applications such as immunology, cancer research, stem cell research, and microbiology. The cell sorter instruments use the principle of flow cytometry, which measure and analyze the characteristics of cells or particles. The cells are labeled with fluorescent markers that specifically bind to certain molecules or structures within the cells, allowing researchers to identify and quantify different cell types or subpopulation on the basis of their fluorescence signals.
The cell sorter market is driven by factors that include continuous technological advancements, such as improvements in sorting speed, increased sensitivity & accuracy, and the ability to handle a wide range of sample volumes. These advancements make cell sorters more efficient, user-friendly, and capable of handling diverse research requirements. In addition, the rise in incidence of chronic diseases, such as cancer, autoimmune disorders, and infectious diseases, creates a need for advanced research tools to understand disease mechanisms and develop effective treatments. Cell sorters facilitate in-depth cellular analysis, aiding in the discovery of novel therapeutic targets and diagnostic biomarkers, which support market growth.
The continuous advancements in cell biology research, such as studying rare cell population, understanding disease mechanisms, and exploring personalized medicine approaches, create a demand for cell sorting technologies and propels market growth. Cell sorters enable researchers to isolate specific cell types or subpopulation for further analysis and experimentation. Moreover, governments, private organizations, and funding agencies are increasingly investing in life sciences research, including cell biology and immunology. This funding supports the development and adoption of advanced research tools, including cell sorters, and drives market growth. However, the high cost of cell sorter instruments and lack of skilled professionals in developing countries limit the adoption of cell sorter and restrain market growth.
The cell sorter market is segmented into product, application, end user, and region. By product, the market is segregated into instruments and consumables & reagents. The instrument segment is further categorized into fluorescence-based droplet cell sorting, magnetic-activated cell sorting, and MEMS- Microfluidics. By application, the market is bifurcated into research applications and clinical applications. The research applications segment is further categorized into immunology & cancer research, stem cell research, drug discovery, and other research applications. By end user, the market is categorized into hospitals & clinical testing laboratories, pharmaceutical & biotechnology companies, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA).
Major key players that operate in the cell sorter market are Becton, Dickinson and Company, Bio-Rad Laboratories, Inc. Cytonome/St, LLC, Danaher Corporation, Harvard Bioscience, Inc., Miltenyi Biotec GmbH, On-Chip Biotechnologies Co., Ltd., Sony Corporation, Sysmex Corporation, and Thermo Fisher Scientific Inc. Key players have adopted product launch, partnership, and acquisition as key developmental strategies to improve the product portfolio of the cell sorter market.
The cell sorter market is driven by factors that include continuous technological advancements, such as improvements in sorting speed, increased sensitivity & accuracy, and the ability to handle a wide range of sample volumes. These advancements make cell sorters more efficient, user-friendly, and capable of handling diverse research requirements. In addition, the rise in incidence of chronic diseases, such as cancer, autoimmune disorders, and infectious diseases, creates a need for advanced research tools to understand disease mechanisms and develop effective treatments. Cell sorters facilitate in-depth cellular analysis, aiding in the discovery of novel therapeutic targets and diagnostic biomarkers, which support market growth.
The continuous advancements in cell biology research, such as studying rare cell population, understanding disease mechanisms, and exploring personalized medicine approaches, create a demand for cell sorting technologies and propels market growth. Cell sorters enable researchers to isolate specific cell types or subpopulation for further analysis and experimentation. Moreover, governments, private organizations, and funding agencies are increasingly investing in life sciences research, including cell biology and immunology. This funding supports the development and adoption of advanced research tools, including cell sorters, and drives market growth. However, the high cost of cell sorter instruments and lack of skilled professionals in developing countries limit the adoption of cell sorter and restrain market growth.
The cell sorter market is segmented into product, application, end user, and region. By product, the market is segregated into instruments and consumables & reagents. The instrument segment is further categorized into fluorescence-based droplet cell sorting, magnetic-activated cell sorting, and MEMS- Microfluidics. By application, the market is bifurcated into research applications and clinical applications. The research applications segment is further categorized into immunology & cancer research, stem cell research, drug discovery, and other research applications. By end user, the market is categorized into hospitals & clinical testing laboratories, pharmaceutical & biotechnology companies, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA).
Major key players that operate in the cell sorter market are Becton, Dickinson and Company, Bio-Rad Laboratories, Inc. Cytonome/St, LLC, Danaher Corporation, Harvard Bioscience, Inc., Miltenyi Biotec GmbH, On-Chip Biotechnologies Co., Ltd., Sony Corporation, Sysmex Corporation, and Thermo Fisher Scientific Inc. Key players have adopted product launch, partnership, and acquisition as key developmental strategies to improve the product portfolio of the cell sorter market.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cell sorter market analysis from 2022 to 2032 to identify the prevailing cell sorter market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the cell sorter market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global cell sorter market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly update (only available with the purchase of an enterprise license)
- 5 additional company profiles of your choice, pre- or post-purchase, as a free update.
- Free updated version (once released) with the purchase of a 1-5 or enterprise user license.
- 16 analyst hours of support (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% free customization (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)
- Free data pack (Excel version) with the purchase of a 1-5 or enterprise user license.
- Free report update, if the report is 6-12 months old or older.
- 24-hour priority response
- Free industry updates and white papers.
Key Market Segments
By Product
- Instruments
- Type
- Fluorescence-based Droplet Cell Sorting
- Magnetic-activated Cell Sorting
- MEMS - Microfluidics
- Consumables and Reagents
By Application
- Research Application
- Type
- Immunology and Cancer Research
- Stem Cell Research
- Drug Discovery
- Other Research Applications
- Clinical Applications
By End User
- Hospitals and Clinical Testing Laboratories
- Pharmaceutical and Biotechnology Companies
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Cytonome/St, LLC
- Danaher Corporation
- Harvard Bioscience, Inc.
- Miltenyi Biotec GmbH
- On-Chip Biotechnologies Co., Ltd.
- Sony Corporation
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: CELL SORTER MARKET, BY PRODUCT
CHAPTER 5: CELL SORTER MARKET, BY APPLICATION
CHAPTER 6: CELL SORTER MARKET, BY END USER
CHAPTER 7: CELL SORTER MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
The Cell Sorter Market is likely to experience a significant growth rate of 8.6% from 2023-2032 owing to advancement in cell sorters and rise in adoption of cell sorters in healthcare and research. According to this report, the cell sorter market was valued at $0.5 billion in 2022, and is estimated to reach $1.3 billion by 2032, growing at a CAGR of 8.6% from 2023 to 2032. Cell sorting is a procedure that involves the separation of a specific cell type from a sample on the basis of its physical or biological characteristics. These characteristics may include size, morphology, viability, and the expression of proteins both inside and outside the cell. By performing cell sorting, a homogeneous population of cells is obtained, which are utilized for various purposes such as research, diagnosis, and therapy.
Key factors driving the growth of the cell sorter market include rise in prevalence of chronic diseases such as cancer and autoimmune conditions, significant advancements in cell sorters such as improvement in sorting speed, faster sorting capabilities allow researchers to analyze larger sample sizes in a shorter amount of time and increasing research productivity. Automated features, such as auto-alignment, self-cleaning, and monitoring systems, reduce the complexity of instrument setup and maintenance. For instance, Sony Biotechnology offers cell sorters, such as the SH800, with intuitive software interfaces and advanced automation features that simplify the sorting process and enhance user experience. Such advancements in cell sorters propel the demand for cell sorting devices and boost market growth.
In addition, government support includes investments in research infrastructure, such as building state-of-the-art laboratories and research centers. These facilities provide researchers with the necessary resources, including advanced equipment such as cell sorters, to conduct innovative research. By establishing and maintaining well-equipped research infrastructure, governments encourage scientists and institutions to embrace advanced technologies such as cell sorters, which in turn drives the market expansion. Furthermore, growth in research and development activities, particularly in fields such as biotechnology, pharmaceuticals, and life sciences. Cell sorters play a vital role in these areas, enabling researchers to isolate and analyze specific cell populations. Thus, the rise in focus on research and development activities drives the demand for cell sorters in the region.
The market offers growth opportunities to the key players in the market. Emerging markets have experienced rapid growth in healthcare infrastructure, such as the establishment of hospitals and research institutes. This expansion creates a demand for advanced medical equipment, including cell sorters, to support research, diagnostics, and therapeutic applications which support the market growth. In addition, the surge in focus on research and development activities in biotechnology, genomics, and personalized medicine led to an increase in the demand for cell sorters. These devices play a crucial role in isolating and analyzing specific cell populations, enabling researchers to study disease mechanisms, drug development, and therapeutic applications.
The cell sorter market is segmented into product, application, end user and region. Based on product, the market is segmented into instruments and consumables and reagents. The instrument segment is further categorized into fluorescence-based droplet cell sorting, magnetic-activated cell sorting, and MEMS- Microfluidics. By application, the market is segmented into research applications and clinical applications. The research applications segment is further categorized into immunology and cancer research, stem cell research, drug discovery, and other research applications. By end user, the market is segmented into hospitals and clinical testing laboratories, pharmaceutical and biotechnology companies, and others. Region wise, the market is analyzed across North America (the U. S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
The key players profiled in the study include Becton, Dickinson and Company, Bio-Rad Laboratories, Inc. Cytonome/St, LLC, Danaher Corporation, Harvard Bioscience, Inc., Miltenyi Biotec GmbH, On-Chip Biotechnologies Co., Ltd., Sony Corporation, Sysmex Corporation, and Thermo Fisher Scientific Inc. The players in the market have been actively engaged in the adoption of various strategies such as product launch, partnership, and acquisition to remain competitive and gain an advantage over the competitors in the market. For instance, in October 2020, On-chip Biotechnologies Co., Ltd. announced a new partnership with PHC Corporation of North America (PHCNA). PHCNA is expected to distribute and market its products in North America. This partnership is anticipated to drive delivery of a platform for sterile, damage-free and contamination-free sorting of cells for On-chip Sort product.
Key Market Insights
By product, the intraoral imaging system segment was the largest revenue contributor to the market and is estimated to reach $700.8 million by 2032, with a highest CAGR of 8.8%.By application, the research application segment dominated the global market in 2022 and is also expected to be the fastest-growing segment with a CAGR of 8.8% during the forecast period.
Based on end user, the pharmaceutical and biotechnology companies segment was the largest revenue contributor to the market in 2022. However, the hospitals and clinical testing laboratories segment is expected to register the highest CAGR during the forecast period.
Based on region, North America garnered the largest revenue share in 2022, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Cytonome/St, LLC
- Danaher Corporation
- Harvard Bioscience, Inc.
- Miltenyi Biotec GmbH
- On-Chip Biotechnologies Co., Ltd.
- Sony Corporation
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
